Description
REAGENT, CHEMISTRY, ANALYZER, TROPONIN
First action · last action
2012-06-01 · 2012-06-01
Transactions
1
First transaction's obligation
$53,050
Base + all options value (sum of deltas)
$53,050
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P2032D
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-06-01+$53,050= $53,050
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-06-01 | +$53,050 | $53,050 | REAGENT, CHEMISTRY, ANALYZER, TROPONIN |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI L3AXXYLB3V56)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24726F0220 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $204,195 | FY2026 |
| 36C24826N0861 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6650 · OPTICAL INSTRUMENTS, TEST EQUIPMENT, COMPONENTS AND ACCESSORIES | $52,650 | FY2026 |
| 36C24826N0821 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $289,849 | FY2026 |
| 36C24826A0029 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $0 | FY2026 |
| 36C25026N0688 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $53,554 | FY2026 |
| 36C25226F0375 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $38,016 | FY2026 |
Other recipients under 6505 from 516-BAY PINES (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24812F4429 | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 516-BAY PINES | $66,125 | FY2012 |
| VA24812F4468 | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 516-BAY PINES | $126,320 | FY2012 |
| VA24812F3711 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 516-BAY PINES | $6,653 | FY2012 |
| VA24812F3681 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 516-BAY PINES | $5,544 | FY2012 |
| VA24812P3665 | MCKESSON CORPORATION | 516-BAY PINES | $14,154 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24812F3824_3600_V797P2032D_3600 · retrieved 2026-09-26.